Drug recall
Apheresis Red Blood Cells, Leukocytes Reduced
FDA recall event 79985 · Class II · Gulf Coast Regional Blood Center
Key facts
| Event ID | 79985 |
|---|---|
| Recall numbers | B-0531-2018 |
| Recalling firm | Gulf Coast Regional Blood Center |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Apheresis products for which quality control procedures were not performed, were distributed. |
| Initiation date | Mar 12, 2018 |
| Report date | May 9, 2018 |
| Termination date | May 2, 2018 |
| City | Houston |
| State | TX |
| Country | United States |
| FEI number | 3002133806 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: